Boston Scientific (BSX) Reports In-Line Q4 EPS
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $43.34 -0.48%
Revenue Growth %: +3.0%
Financial Fact:
Net income (loss): 228M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +3.0%
Financial Fact:
Net income (loss): 228M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q4 EPS of $0.34, in-line with the analyst estimate of $0.34. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.38 billion.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi cuts Boston Scientific rating to neutral, lowers price target
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Westinghouse said to seek over $50 billion valuation in planned IPO
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
